Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: TG Therapeutics Inc., 3 years.
TG Therapeutics Inc.
Director
Kenon Holdings Ltd.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 7, 2026 | TG Therapeutics Inc. | Gift | −500 | — | — |
| Aug 7, 2026 | TG Therapeutics Inc. | Gift | −450 | — | — |
| Aug 6, 2026 | TG Therapeutics Inc. | Gift | −5,100 | — | — |
| Jan 29, 2026 | TG Therapeutics Inc. | Gift | −13,197 | — | — |
| Jan 28, 2026 | TG Therapeutics Inc. | Gift | −30,000 | — | — |
| Jun 12, 2025 | TG Therapeutics Inc. | Grant or award | +21,408 | — | — |
| Mar 10, 2025 | TG Therapeutics Inc. | Gift | −6,000 | — | — |
| Nov 12, 2024 | TG Therapeutics Inc. | Gift | −5,000 | — | — |
| Nov 11, 2024 | TG Therapeutics Inc. | Open-market sale | −25,000 | $30.20 | $755,000 |
| Jun 19, 2024 | TG Therapeutics Inc. | Grant or award | +22,250 | — | — |
| Mar 12, 2024 | TG Therapeutics Inc. | Open-market sale | −22,000 | $15.97 | $351,340 |
| Jan 5, 2024 | TG Therapeutics Inc. | Open-market sale | −17,500 | $19.03 | $333,025 |
| Sep 28, 2023 | TG Therapeutics Inc. | Grant or award | +20,000 | — | — |
| Jan 4, 2023 | TG Therapeutics Inc. | Open-market sale | −30,000 | $11.10 | $333,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.